WO2007132005A2 - Composés hybrides à base de polyol(s) et à base d'au moins une autre entité moléculaire, polymères ou non, notamment de type polyorganosiloxane, son procédé de préparation et ses applications - Google Patents
Composés hybrides à base de polyol(s) et à base d'au moins une autre entité moléculaire, polymères ou non, notamment de type polyorganosiloxane, son procédé de préparation et ses applications Download PDFInfo
- Publication number
- WO2007132005A2 WO2007132005A2 PCT/EP2007/054702 EP2007054702W WO2007132005A2 WO 2007132005 A2 WO2007132005 A2 WO 2007132005A2 EP 2007054702 W EP2007054702 W EP 2007054702W WO 2007132005 A2 WO2007132005 A2 WO 2007132005A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- entity
- synthon
- hybrid compound
- hybrid
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 84
- 229920005862 polyol Polymers 0.000 title claims abstract description 38
- 229920000642 polymer Polymers 0.000 title claims abstract description 28
- 150000003077 polyols Chemical class 0.000 title claims abstract description 27
- 238000000034 method Methods 0.000 title claims description 20
- 238000002360 preparation method Methods 0.000 title description 15
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 30
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 23
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 12
- 125000000304 alkynyl group Chemical group 0.000 claims abstract description 11
- 239000004952 Polyamide Substances 0.000 claims abstract description 10
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 10
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 10
- 239000011707 mineral Substances 0.000 claims abstract description 10
- 229920002647 polyamide Polymers 0.000 claims abstract description 10
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 10
- 229920001515 polyalkylene glycol Polymers 0.000 claims abstract description 9
- 125000003118 aryl group Chemical group 0.000 claims abstract description 8
- 239000002537 cosmetic Substances 0.000 claims abstract description 8
- 239000004793 Polystyrene Substances 0.000 claims abstract description 7
- 229920000728 polyester Polymers 0.000 claims abstract description 7
- 229920002223 polystyrene Polymers 0.000 claims abstract description 7
- 239000000463 material Substances 0.000 claims abstract description 4
- 239000000203 mixture Substances 0.000 claims description 46
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 45
- 150000001720 carbohydrates Chemical class 0.000 claims description 43
- -1 saccharide polyols Chemical class 0.000 claims description 28
- 238000007306 functionalization reaction Methods 0.000 claims description 25
- 239000002243 precursor Substances 0.000 claims description 25
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 24
- 150000001413 amino acids Chemical class 0.000 claims description 24
- 229910052799 carbon Inorganic materials 0.000 claims description 23
- 229920001577 copolymer Polymers 0.000 claims description 21
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 20
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 18
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 18
- 125000003277 amino group Chemical group 0.000 claims description 17
- 239000012429 reaction media Substances 0.000 claims description 17
- 150000002772 monosaccharides Chemical group 0.000 claims description 15
- 125000005843 halogen group Chemical group 0.000 claims description 13
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 13
- 239000000178 monomer Substances 0.000 claims description 12
- 230000008569 process Effects 0.000 claims description 12
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 10
- 125000001246 bromo group Chemical group Br* 0.000 claims description 10
- 238000006352 cycloaddition reaction Methods 0.000 claims description 10
- 239000000741 silica gel Substances 0.000 claims description 10
- 229910002027 silica gel Inorganic materials 0.000 claims description 10
- 235000001014 amino acid Nutrition 0.000 claims description 9
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims description 8
- 238000004587 chromatography analysis Methods 0.000 claims description 8
- 229910052802 copper Inorganic materials 0.000 claims description 8
- 230000007246 mechanism Effects 0.000 claims description 8
- 229920001451 polypropylene glycol Polymers 0.000 claims description 8
- 239000004215 Carbon black (E152) Substances 0.000 claims description 7
- 125000004429 atom Chemical group 0.000 claims description 7
- 229930195733 hydrocarbon Natural products 0.000 claims description 7
- 150000002430 hydrocarbons Chemical group 0.000 claims description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 7
- 229910052757 nitrogen Inorganic materials 0.000 claims description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- 239000003054 catalyst Substances 0.000 claims description 6
- 150000002334 glycols Chemical class 0.000 claims description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 6
- 239000002798 polar solvent Substances 0.000 claims description 6
- 239000002453 shampoo Substances 0.000 claims description 6
- 125000004469 siloxy group Chemical group [SiH3]O* 0.000 claims description 6
- 150000003573 thiols Chemical class 0.000 claims description 6
- 150000008064 anhydrides Chemical class 0.000 claims description 5
- 150000007942 carboxylates Chemical class 0.000 claims description 5
- 239000000839 emulsion Substances 0.000 claims description 5
- 239000012948 isocyanate Substances 0.000 claims description 5
- 150000002513 isocyanates Chemical class 0.000 claims description 5
- 229910052751 metal Inorganic materials 0.000 claims description 5
- 239000002184 metal Substances 0.000 claims description 5
- 229910052760 oxygen Inorganic materials 0.000 claims description 5
- 229920002857 polybutadiene Polymers 0.000 claims description 5
- 229920001059 synthetic polymer Polymers 0.000 claims description 5
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 claims description 4
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 claims description 4
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 4
- 239000003638 chemical reducing agent Substances 0.000 claims description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 4
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 4
- 235000010323 ascorbic acid Nutrition 0.000 claims description 3
- 239000011668 ascorbic acid Substances 0.000 claims description 3
- 229920001400 block copolymer Polymers 0.000 claims description 3
- 239000003599 detergent Substances 0.000 claims description 3
- 229940113088 dimethylacetamide Drugs 0.000 claims description 3
- 239000003480 eluent Substances 0.000 claims description 3
- 238000001704 evaporation Methods 0.000 claims description 3
- 230000008020 evaporation Effects 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 239000000344 soap Substances 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 125000000923 (C1-C30) alkyl group Chemical group 0.000 claims description 2
- 108010024636 Glutathione Proteins 0.000 claims description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 2
- 229940072107 ascorbate Drugs 0.000 claims description 2
- 229910052804 chromium Inorganic materials 0.000 claims description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 2
- 235000018417 cysteine Nutrition 0.000 claims description 2
- 229960003180 glutathione Drugs 0.000 claims description 2
- 238000011065 in-situ storage Methods 0.000 claims description 2
- 229910052742 iron Inorganic materials 0.000 claims description 2
- 229910052749 magnesium Inorganic materials 0.000 claims description 2
- 229910052748 manganese Inorganic materials 0.000 claims description 2
- 229910052759 nickel Inorganic materials 0.000 claims description 2
- 239000012454 non-polar solvent Substances 0.000 claims description 2
- 239000007764 o/w emulsion Substances 0.000 claims description 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 2
- 239000003586 protic polar solvent Substances 0.000 claims description 2
- 230000003381 solubilizing effect Effects 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- 239000004094 surface-active agent Substances 0.000 claims description 2
- 230000008961 swelling Effects 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 239000008096 xylene Substances 0.000 claims description 2
- 229910052725 zinc Inorganic materials 0.000 claims description 2
- 239000004698 Polyethylene Substances 0.000 claims 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical class CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 claims 1
- 150000002924 oxiranes Chemical class 0.000 claims 1
- 229920000233 poly(alkylene oxides) Polymers 0.000 claims 1
- 229920000573 polyethylene Polymers 0.000 claims 1
- 229920006301 statistical copolymer Polymers 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 150000003722 vitamin derivatives Chemical class 0.000 claims 1
- 239000003995 emulsifying agent Substances 0.000 abstract description 4
- 229920001282 polysaccharide Polymers 0.000 description 25
- 239000005017 polysaccharide Substances 0.000 description 25
- 150000004676 glycans Chemical class 0.000 description 24
- 238000006243 chemical reaction Methods 0.000 description 21
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 14
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 13
- 239000011734 sodium Substances 0.000 description 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 12
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 12
- 229910052739 hydrogen Inorganic materials 0.000 description 12
- 150000001345 alkine derivatives Chemical class 0.000 description 11
- 239000010949 copper Substances 0.000 description 11
- 239000004205 dimethyl polysiloxane Substances 0.000 description 11
- 239000002609 medium Substances 0.000 description 11
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 10
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 10
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 9
- 102000004196 processed proteins & peptides Human genes 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- 238000004809 thin layer chromatography Methods 0.000 description 9
- 150000002482 oligosaccharides Chemical class 0.000 description 8
- 238000006736 Huisgen cycloaddition reaction Methods 0.000 description 7
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 239000001257 hydrogen Substances 0.000 description 7
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 125000004122 cyclic group Chemical group 0.000 description 6
- 150000002118 epoxides Chemical class 0.000 description 6
- 238000006459 hydrosilylation reaction Methods 0.000 description 6
- 150000002825 nitriles Chemical class 0.000 description 6
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 6
- 229920001542 oligosaccharide Polymers 0.000 description 6
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 5
- 244000303965 Cyamopsis psoralioides Species 0.000 description 5
- 101000641959 Homo sapiens Villin-1 Proteins 0.000 description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 5
- 102100033419 Villin-1 Human genes 0.000 description 5
- 150000001540 azides Chemical class 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 239000000470 constituent Substances 0.000 description 5
- 238000010511 deprotection reaction Methods 0.000 description 5
- 238000004108 freeze drying Methods 0.000 description 5
- 238000003760 magnetic stirring Methods 0.000 description 5
- 238000004949 mass spectrometry Methods 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 description 5
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 5
- 229920001296 polysiloxane Polymers 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 235000010378 sodium ascorbate Nutrition 0.000 description 5
- 229960005055 sodium ascorbate Drugs 0.000 description 5
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 5
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 150000003852 triazoles Chemical class 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- 0 CC1[C@](*)OC(*)[C@]2C1C*2 Chemical compound CC1[C@](*)OC(*)[C@]2C1C*2 0.000 description 4
- 240000008886 Ceratonia siliqua Species 0.000 description 4
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- 150000001412 amines Chemical group 0.000 description 4
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000009833 condensation Methods 0.000 description 4
- 230000005494 condensation Effects 0.000 description 4
- 229910000365 copper sulfate Inorganic materials 0.000 description 4
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 4
- 230000008030 elimination Effects 0.000 description 4
- 238000003379 elimination reaction Methods 0.000 description 4
- 150000002338 glycosides Chemical group 0.000 description 4
- 229920001184 polypeptide Polymers 0.000 description 4
- JKANAVGODYYCQF-UHFFFAOYSA-N prop-2-yn-1-amine Chemical compound NCC#C JKANAVGODYYCQF-UHFFFAOYSA-N 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 3
- 229920000858 Cyclodextrin Polymers 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 229920002774 Maltodextrin Polymers 0.000 description 3
- 229910018557 Si O Inorganic materials 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 150000001719 carbohydrate derivatives Chemical class 0.000 description 3
- 150000001721 carbon Chemical group 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000002781 deodorant agent Substances 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 210000004417 patella Anatomy 0.000 description 3
- LIVNPJMFVYWSIS-UHFFFAOYSA-N silicon monoxide Inorganic materials [Si-]#[O+] LIVNPJMFVYWSIS-UHFFFAOYSA-N 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 150000003536 tetrazoles Chemical class 0.000 description 3
- CSCFHHDGJVUZFZ-UHFFFAOYSA-N 1-azidooctadecane Chemical compound CCCCCCCCCCCCCCCCCCN=[N+]=[N-] CSCFHHDGJVUZFZ-UHFFFAOYSA-N 0.000 description 2
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
- 239000005913 Maltodextrin Substances 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 238000006640 acetylation reaction Methods 0.000 description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 230000001166 anti-perspirative effect Effects 0.000 description 2
- 239000003213 antiperspirant Substances 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 125000004181 carboxyalkyl group Chemical group 0.000 description 2
- 125000002843 carboxylic acid group Chemical group 0.000 description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000001212 derivatisation Methods 0.000 description 2
- 150000002016 disaccharides Chemical class 0.000 description 2
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical compound [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 125000005677 ethinylene group Chemical group [*:2]C#C[*:1] 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- DBTMGCOVALSLOR-AXAHEAMVSA-N galactotriose Natural products OC[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](CO)O[C@@H](O[C@H]3[C@@H](O)[C@H](O)O[C@@H](CO)[C@@H]3O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O DBTMGCOVALSLOR-AXAHEAMVSA-N 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 229920000578 graft copolymer Polymers 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- CBFCDTFDPHXCNY-UHFFFAOYSA-N icosane Chemical compound CCCCCCCCCCCCCCCCCCCC CBFCDTFDPHXCNY-UHFFFAOYSA-N 0.000 description 2
- 239000013067 intermediate product Substances 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 229940035034 maltodextrin Drugs 0.000 description 2
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 2
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 238000003408 phase transfer catalysis Methods 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 229920000768 polyamine Polymers 0.000 description 2
- TVDSBUOJIPERQY-UHFFFAOYSA-N prop-2-yn-1-ol Chemical compound OCC#C TVDSBUOJIPERQY-UHFFFAOYSA-N 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 2
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 1
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical class O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 1
- LGQKSQQRKHFMLI-SJYYZXOBSA-N (2s,3r,4s,5r)-2-[(3r,4r,5r,6r)-4,5,6-trihydroxyoxan-3-yl]oxyoxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CO[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)OC1 LGQKSQQRKHFMLI-SJYYZXOBSA-N 0.000 description 1
- KFEUJDWYNGMDBV-UHFFFAOYSA-N (N-Acetyl)-glucosamin-4-beta-galaktosid Natural products OC1C(NC(=O)C)C(O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 KFEUJDWYNGMDBV-UHFFFAOYSA-N 0.000 description 1
- SMXIAMQOQUZJRO-UHFFFAOYSA-N 1-[methyl-bis(trimethylsilyloxy)silyl]propan-2-yloxymethanol Chemical compound C[Si](O[Si](O[Si](C)(C)C)(CC(C)OCO)C)(C)C SMXIAMQOQUZJRO-UHFFFAOYSA-N 0.000 description 1
- WSULSMOGMLRGKU-UHFFFAOYSA-N 1-bromooctadecane Chemical compound CCCCCCCCCCCCCCCCCCBr WSULSMOGMLRGKU-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- MSWZFWKMSRAUBD-CBPJZXOFSA-N 2-amino-2-deoxy-D-mannopyranose Chemical compound N[C@@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-CBPJZXOFSA-N 0.000 description 1
- QIGJYVCQYDKYDW-UHFFFAOYSA-N 3-O-alpha-D-mannopyranosyl-D-mannopyranose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(CO)OC(O)C1O QIGJYVCQYDKYDW-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- LGQKSQQRKHFMLI-UHFFFAOYSA-N 4-O-beta-D-xylopyranosyl-beta-D-xylopyranose Natural products OC1C(O)C(O)COC1OC1C(O)C(O)C(O)OC1 LGQKSQQRKHFMLI-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PZPXDAEZSA-N 4β-mannobiose Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-PZPXDAEZSA-N 0.000 description 1
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 101150043532 CISH gene Proteins 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- 241000219748 Cyamopsis Species 0.000 description 1
- WQZGKKKJIJFFOK-CBPJZXOFSA-N D-Gulose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O WQZGKKKJIJFFOK-CBPJZXOFSA-N 0.000 description 1
- WQZGKKKJIJFFOK-WHZQZERISA-N D-aldose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-WHZQZERISA-N 0.000 description 1
- WQZGKKKJIJFFOK-IVMDWMLBSA-N D-allopyranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-IVMDWMLBSA-N 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- SQNRKWHRVIAKLP-UHFFFAOYSA-N D-xylobiose Natural products O=CC(O)C(O)C(CO)OC1OCC(O)C(O)C1O SQNRKWHRVIAKLP-UHFFFAOYSA-N 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- 102000002068 Glycopeptides Human genes 0.000 description 1
- 108010015899 Glycopeptides Proteins 0.000 description 1
- 244000299507 Gossypium hirsutum Species 0.000 description 1
- 238000005873 Huisgen reaction Methods 0.000 description 1
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 description 1
- KFEUJDWYNGMDBV-LODBTCKLSA-N N-acetyllactosamine Chemical compound O[C@@H]1[C@@H](NC(=O)C)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KFEUJDWYNGMDBV-LODBTCKLSA-N 0.000 description 1
- HESSGHHCXGBPAJ-UHFFFAOYSA-N N-acetyllactosamine Natural products CC(=O)NC(C=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O HESSGHHCXGBPAJ-UHFFFAOYSA-N 0.000 description 1
- 229910003849 O-Si Inorganic materials 0.000 description 1
- DKXNBNKWCZZMJT-UHFFFAOYSA-N O4-alpha-D-Mannopyranosyl-D-mannose Natural products O=CC(O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O DKXNBNKWCZZMJT-UHFFFAOYSA-N 0.000 description 1
- AYRXSINWFIIFAE-UHFFFAOYSA-N O6-alpha-D-Galactopyranosyl-D-galactose Natural products OCC1OC(OCC(O)C(O)C(O)C(O)C=O)C(O)C(O)C1O AYRXSINWFIIFAE-UHFFFAOYSA-N 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 229910003872 O—Si Inorganic materials 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- HIWPGCMGAMJNRG-ACCAVRKYSA-N Sophorose Natural products O([C@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HIWPGCMGAMJNRG-ACCAVRKYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- FTNIPWXXIGNQQF-UHFFFAOYSA-N UNPD130147 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(OC4C(OC(O)C(O)C4O)CO)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O FTNIPWXXIGNQQF-UHFFFAOYSA-N 0.000 description 1
- LUEWUZLMQUOBSB-UHFFFAOYSA-N UNPD55895 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(O)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O LUEWUZLMQUOBSB-UHFFFAOYSA-N 0.000 description 1
- 229920002000 Xyloglucan Polymers 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 150000001323 aldoses Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- FBJQEBRMDXPWNX-SMGIPPFUSA-N alpha-D-Galp-(1->6)-alpha-D-Galp-(1->6)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H]2[C@H]([C@H](O)[C@@H](O)C(O)O2)O)O1 FBJQEBRMDXPWNX-SMGIPPFUSA-N 0.000 description 1
- LHAOFBCHXGZGOR-NAVBLJQLSA-N alpha-D-Manp-(1->3)-alpha-D-Manp-(1->2)-alpha-D-Manp Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO)O1 LHAOFBCHXGZGOR-NAVBLJQLSA-N 0.000 description 1
- GZCGUPFRVQAUEE-UHFFFAOYSA-N alpha-D-galactose Natural products OCC(O)C(O)C(O)C(O)C=O GZCGUPFRVQAUEE-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-STGXQOJASA-N alpha-D-lyxopyranose Chemical compound O[C@@H]1CO[C@H](O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-STGXQOJASA-N 0.000 description 1
- BNABBHGYYMZMOA-AHIHXIOASA-N alpha-maltoheptaose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](O[C@H](O[C@@H]3[C@H](O[C@H](O[C@@H]4[C@H](O[C@H](O[C@@H]5[C@H](O[C@H](O[C@@H]6[C@H](O[C@H](O)[C@H](O)[C@H]6O)CO)[C@H](O)[C@H]5O)CO)[C@H](O)[C@H]4O)CO)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O BNABBHGYYMZMOA-AHIHXIOASA-N 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- QLTSDROPCWIKKY-PMCTYKHCSA-N beta-D-glucosaminyl-(1->4)-beta-D-glucosamine Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O)[C@@H](CO)O1 QLTSDROPCWIKKY-PMCTYKHCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- DLRVVLDZNNYCBX-ZZFZYMBESA-N beta-melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 DLRVVLDZNNYCBX-ZZFZYMBESA-N 0.000 description 1
- HIWPGCMGAMJNRG-UHFFFAOYSA-N beta-sophorose Natural products OC1C(O)C(CO)OC(O)C1OC1C(O)C(O)C(O)C(CO)O1 HIWPGCMGAMJNRG-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 150000001773 cellobioses Chemical class 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 description 1
- 238000010549 co-Evaporation Methods 0.000 description 1
- 239000007957 coemulsifier Substances 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 229940125797 compound 12 Drugs 0.000 description 1
- 229940126543 compound 14 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- 239000000412 dendrimer Substances 0.000 description 1
- 229920000736 dendritic polymer Polymers 0.000 description 1
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical group C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 1
- 125000005388 dimethylhydrogensiloxy group Chemical group 0.000 description 1
- 229960001275 dimeticone Drugs 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000006266 etherification reaction Methods 0.000 description 1
- 235000019439 ethyl acetate Nutrition 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- DLRVVLDZNNYCBX-CQUJWQHSSA-N gentiobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-CQUJWQHSSA-N 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 150000002431 hydrogen Chemical group 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 150000002453 idose derivatives Chemical class 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000009878 intermolecular interaction Effects 0.000 description 1
- 230000008863 intramolecular interaction Effects 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- FBJQEBRMDXPWNX-FYHZSNTMSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H]2[C@H]([C@H](O)[C@@H](O)C(O)O2)O)O1 FBJQEBRMDXPWNX-FYHZSNTMSA-N 0.000 description 1
- 150000002584 ketoses Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- QIGJYVCQYDKYDW-LCOYTZNXSA-N laminarabiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1O QIGJYVCQYDKYDW-LCOYTZNXSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- FJCUPROCOFFUSR-UHFFFAOYSA-N malto-pentaose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 FJCUPROCOFFUSR-UHFFFAOYSA-N 0.000 description 1
- UYQJCPNSAVWAFU-UHFFFAOYSA-N malto-tetraose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)O1 UYQJCPNSAVWAFU-UHFFFAOYSA-N 0.000 description 1
- FJCUPROCOFFUSR-GMMZZHHDSA-N maltopentaose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O[C@@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@@H](CO)O2)O)[C@@H](CO)O1 FJCUPROCOFFUSR-GMMZZHHDSA-N 0.000 description 1
- LUEWUZLMQUOBSB-OUBHKODOSA-N maltotetraose Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O[C@@H]3[C@@H](O[C@@H](O)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-OUBHKODOSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 229940038384 octadecane Drugs 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003961 organosilicon compounds Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 1
- 235000019175 phylloquinone Nutrition 0.000 description 1
- 239000011772 phylloquinone Substances 0.000 description 1
- 229960001898 phytomenadione Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 229920001610 polycaprolactone Polymers 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 229920000903 polyhydroxyalkanoate Polymers 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 150000003138 primary alcohols Chemical group 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical group CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- PZDOWFGHCNHPQD-VNNZMYODSA-N sophorose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](C=O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PZDOWFGHCNHPQD-VNNZMYODSA-N 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 150000004044 tetrasaccharides Chemical class 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 150000004043 trisaccharides Chemical class 0.000 description 1
- ZQTYRTSKQFQYPQ-UHFFFAOYSA-N trisiloxane Chemical compound [SiH3]O[SiH2]O[SiH3] ZQTYRTSKQFQYPQ-UHFFFAOYSA-N 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
- C08G77/04—Polysiloxanes
- C08G77/38—Polysiloxanes modified by chemical after-treatment
- C08G77/382—Polysiloxanes modified by chemical after-treatment containing atoms other than carbon, hydrogen, oxygen or silicon
- C08G77/388—Polysiloxanes modified by chemical after-treatment containing atoms other than carbon, hydrogen, oxygen or silicon containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/896—Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate
- A61K8/898—Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate containing nitrogen, e.g. amodimethicone, trimethyl silyl amodimethicone or dimethicone propyl PG-betaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H23/00—Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
- C08G77/04—Polysiloxanes
- C08G77/22—Polysiloxanes containing silicon bound to organic groups containing atoms other than carbon, hydrogen and oxygen
- C08G77/26—Polysiloxanes containing silicon bound to organic groups containing atoms other than carbon, hydrogen and oxygen nitrogen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
- C08G77/42—Block-or graft-polymers containing polysiloxane sequences
- C08G77/46—Block-or graft-polymers containing polysiloxane sequences containing polyether sequences
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
Definitions
- the present invention relates to novel hybrid structures comprising at least one polyol (PO) -for example oligomeric or polymeric-entity and at least one entity A which may be of varied nature, for example polymer (eg polyorganosiloxane-POS), hydrocarbon-based or mineral.
- PO polyol
- entity A which may be of varied nature, for example polymer (eg polyorganosiloxane-POS), hydrocarbon-based or mineral.
- the link or the links between this entity Po and this entity A are obtained according to the chemical mechanism designated by the name "click chemistry", in which an azide (or azide) reactive unit reacts with a reactive unit of the alkynyl or nitrile type, for form a triazole or tetrazole bond (Ro).
- the invention also relates to the process for obtaining these hybrid structures as well as their applications as amphiphilic compounds, for example.
- synthons that is to say the intermediate products bearing azide and / or alkynyl and / or nitrile type functions and involved in the preparation of these hybrid structures.
- the polyols especially, but not exclusively, concerned by the present invention include oligosaccharides or polysaccharides (linear, branched or cyclic) at least partly constituted by at least two, preferably at least three, monosaccharide units, connected between they have osidic bonds.
- These particular polysaccharide polymers-polyols are of particular interest in view of their physicochemical properties (hydrophilic, hydrolyzable, bioresorbable, etc.), their chemical complexity offering multiple possibilities in terms of structure and properties, their high availability and their natural origin, among others. This natural origin can make them particularly attractive from an environmental and / or toxicological and / or commercial point of view.
- POS silicones
- hybrid structures based on polysaccharides and POS so as to have, for example, emulsifying compounds that can be used in particular in cosmetic compositions such as skin care compositions, protective compositions and the like. and solar treatment, shampoo compositions, deodorant compositions and / or antiperspirant, for example in the form of "stick", gel or lotion, among others.
- the polysaccharide entity and the POS entity combine their respective advantages.
- the polysaccharide entity by the presence of its numerous hydroxyl functions, can develop strong intra or intermolecular interactions, both in a hydrophobic medium and in a hydrophilic medium. This molecular recognition type behavior makes it possible to obtain gels-type organizations and / or to promote interactions with polar surfaces such as textiles (i.a. cotton), hair.
- the POS entity brings two major benefits. The first is the flexibility which gives this POS entity a high reactivity and an ability to adapt its molecular conformation according to the substrate (s) present. The second advantage, among others, is the hydrophobic character of this POS entity which provides properties of low surface energy.
- Wacker-Belsil® SPG 128 VP is a cyclopentadimethylsiloxane of which a part of the siloxy units D is substituted by a polyglucoside chain connected to silicon by a ball joint comprising two oxygen bridges and of which another part of the units D is substituted with an alkyl radical of - (CH) type. 2 ) W-CH 3 , w being a natural integer.
- EP-BO 612 759 describes organosilicon compounds comprising a glycoside residue obtained by reacting a mono- or polysaccharide (1 to 10 monosaccharide units) alkenylated with a POS, for example a disiloxane, bearing SiH units.
- the alkenyl group is introduced directly on the oligosaccharide or polysaccharide, unprotected anomer position, with alkyl oxyethanol, in the presence of a strong acid, to 100 0 C.
- the hydrosilylation is carried out at the Speier platinum catalyst aid in isopranol at 100 ° C.
- the hybrid compound obtained in the examples has the following formula:
- WO-A-2005/087843 discloses a graft polymer comprising a polyorganosiloxane backbone and glycoside units (mono and / or polysaccharides).
- WO-A-2005/087843 describes the preparation of an allyl-functionalized cellobiose grafted polydimethylsiloxane. To do this, the cellobiose is reacted with allylamine. After fixing the allylamine unit on the anomeric cellobiose carbon, the amine function and a part of the primary hydroxyls are protected by acetylation. The remaining hydroxyl functions are protected by substitution of their hydrogen by a trimethylsilyl function.
- hydrosilylation of polydimethylsiloxane end dimethylhydrogensiloxy is then carried out in the presence of Karstedt platinum at a temperature of 70 0 C. is then carried out deprotection of the grafted POS at its ends by the disaccharide cellobiose, using a mixture of tetrahydrofuran / methanol, in acid medium.
- the reaction scheme is as follows: hydrosilylation
- saccharide protection / deprotection constraints are a definite handicap for these known polyorganosiloxane / glycoside graft polymers and their process for obtaining them.
- Huisgen and Szeimies [(a) Huisgen, R .; Szeimies, G .; Moebius, L. Chem. Ber. 1967, 100, 2494. (b) Huisgen, R .; Knorr, R .; Moebius, L .; Szeimies, G. Chem. Ber. 1965, 98, 4014] were the first to carry out the 1,3-dipolar cycloaddition of an azido derivative on an alkyne derivative at high temperature. The scheme of this cycloaddition is as follows:
- this 1,3-dipolar cycloaddition makes it possible, for example, to obtain hybrid systems (cf products 1 to 10) comprising, on the one hand, phenyl rings and, on the other hand, inert or branched, optionally unsaturated and optionally hydroxyl-bearing cyclic molecules, and a hybrid system (11) comprising a patella triazole linking, on the one hand, a propane diol residue and, on the other hand, a polycyclic dihydroxy compound.
- FIGS. 6 to 8 of WO-A-03/101972 it is possible to functionalize amino-biological molecules such as erythromicne (see FIG. 6), as well as molecules comprising nuclei. polyazides or polyalkyls (see Figures 7 and 8).
- WO-A-03/101972 does not disclose hybrid compounds comprising cycloaddition linked entities "" click chemistry "to different polyol entities or POS entities, polyalkylene glycol, polyamide, polyester, alkyl, alkenyl, alkynyl, aryl and their combinations, nor to mineral materials such as silica.
- the application WO-A-2005/118625 describes other applications of the 1,3-dipolar cycladdition click chemistry aiming to produce hybrid systems comprising an entity A corresponding to a carbohydrate linked by a 5-membered cyclic ring. 1-2-3 triazole at an entity B consisting of an amino acid or an amino acid analogue or at a C entity representing a polypeptide or polypeptide analogue.
- entity B consisting of an amino acid or an amino acid analogue or at a C entity representing a polypeptide or polypeptide analogue.
- carbohydrate designates both mono and polysaccharides, in which the hydroxyl groups are optionally substituted with hydrogen, an amino group, thiol or groups of hetero atoms.
- the 1,3-dipolar cycloaddition is carried out by protecting the hydroxyl groups of the saccharide with an acetyl group and the amino group of the amino acid with a Boc group, and by using a copper catalyst and diisopropylethylamine in a tetrahydrofuran solvent medium. .
- the pseudo-glycoamino acids and glycopeptides obtained can be used for the treatment of bacterial infections. It should be noted that in the AB or AC systems according to WO-A-2005/118625, the substitution by B or C of the "carbohydrate" entity A is carried out exclusively on the anomeric carbon of A.
- One of the essential objectives of the present invention is to provide other hybrid compounds obtained by "click chemistry”.
- Another essential objective of the invention is to provide novel hybrid compounds based on the polyol entity (s) connected (s) by at least one triazole or pentacyclic tetrazole to at least one A entity, these hybrid compounds being capable of to be exploited in many applications as industrial (emulsifiers) as biological.
- Another essential objective of the invention is to provide hybrid compounds comprising one or more Po (polymer) -polyols, for example polysaccharide, entities linked by triazole or tetrazole pentacyclic patellae obtained by "click chemistry" to at least one A entity.
- Another essential objective of the invention is to provide hybrid polysaccharide / POS compounds linked by at least one patella resulting from a 1,3-dipolar cycloaddition of an azido or nitrile derivative on an alkyne derivative, with a copper catalysis. by "click chemistry”.
- Another essential object of the invention is to provide hybrid compounds comprising one or more Po (polymer) -polyols, for example polysaccharide, entities, these compounds being capable of being prepared without heavy steps of protection / deprotection of the reagents, in particular saccharides.
- Po polymer
- polyols for example polysaccharide
- Another essential objective of the invention is to provide a simple process for the preparation of hybrid compounds comprising one or more Po (polymer) -polyols, for example polysaccharide, entities, in particular without heavy steps of protection / deprotection of the reagents, in particular saccharides.
- Another essential object of the invention is to provide cosmetic compositions, shampoo compositions, cleaning compositions, comprising hybrid compounds as defined in the objectives above.
- Po-Ro-A comprising at least one polyol entity (Po) and in which at least one of the Po atoms is substituted by at least one set of following general formula (I):
- Ro is a ball of formula (IL1) or (II.2) below:
- the polyol entity Po is selected from polymeric synthetic non-saccharide polyols, or from saccharides (hydrogenated or otherwise) comprising at least two, preferably at least three, monosaccharide units,
- - A is a mineral or organic entity, optionally a polymer; and in case of presence of a plurality of A-entities per molecule of hybrid compound; said A-entities are identical to or different from one another, the organic entity A being chosen from a compound selected from the group consisting of:
- alkyls alkenyls, alkynyls, aryls and combinations thereof - and combinations thereof.
- hybrid refers to structures Po-Ro-- A homogeneous (Po is identical to A) or heterogeneous (Po is different from A).
- Z represents a carbon atom, it is also bonded to a hydrogen atom not usually represented, so as to satisfy the valence of said carbon.
- at least one of the hydroxyl functions of the polyol entity (Po) is substituted by at least one set of the following general formula (I): """" Ro A as defined above.
- the hybrid compound according to the invention is characterized in that the Ro ball or at least one of the ball joints Ro is connected to the entity Po and / or to the entity A by a -L- divalent link.
- L is a spacing pattern.
- L may for example be a hydrocarbon unit or an atom such as O or S.
- the term "hydro (geno) carbon unit” designates a unit comprising, for example, at least one carbon atom and / or or at least one hydrogen. This includes the bonds "ester", “amide”, “imine” ...
- the hybrid compound according to the invention is characterized in that none of the rollers Ro is connected to the entity Po by a link -L- divalent and in that said compound hybrid comprises at least one entity A free of amino acid (s) and / or peptide (s) and / or their analogue (s) and / or derivative (s).
- the present invention also provides a novel process for obtaining the abovementioned hybrid compounds.
- the synthon Po-X is reacted with the synthon AY according to a cycloaddition mechanism, so as to obtain a hybrid compound Po-Ro-A comprising at least one polyol (Po) entity in which at least one of the hydroxyl functions of Po is substituted by at least one set of the following general formula (T) - with Ro and A as defined above;
- reaction medium is separated so as to recover it.
- Such a method is particularly advantageous because of its simplicity, its economy, its eco-compatibility and the multiplicity (variety) of the products that it makes it possible to obtain.
- Po-X synthons and AY synthons it is possible to implement, in place of or in addition to the Po-X synthons and AY synthons, mixed Po-XY synthons each comprising at least one reactive unit X and at least one less Y reactive unit and A-XY mixed synthons each comprising at least one reactive unit X and at least one Y reactant motif, such that these Po-XY and A-XY synthons are able to react together or on themselves .
- the invention also relates to: - Po-X synthons comprising at least one reactive unit X having at least one reactive end of formula (
- AX synthons comprising a reactive unit X having at least one reactive unit X having at least one reactive end of formula (VII.1.3):
- the invention finally relates to the uses of these hybrid compounds and the compositions comprising them.
- the Ro bonded joint of formula (IL1) or Ql.2) is at the heart of the hybrid compounds according to the invention.
- the free valency bond of nitrogen in position 1 in formulas (II.1) and (II.2) connects Ro to Po and the free valence bond of carbon or atom.
- Z in position 4 or 5 in the formulas (II.1) and (II.2) connects the rotule Ro to A.
- the free valent bond of nitrogen in position 1 in formulas (II.1) and (II.2) connects Ro to A and the free bond of carbon or Z in position 4 or 5 in formulas (II.1) and (II.2) connects the Ro joint to Po.
- hybrid compounds according to the invention are not limited to compounds comprising a single Ro ball, but also cover hybrid compounds each comprising several Ro balloons, identical or different from each other.
- the latter can comprise in particular at least one of the links Li, L 2 , L 3 , L 4 , as defined above in the formulas (VIL 1.1). (VII.2.1). (VIL 1.3). (VII.2.4) synthons Po-X, Po-Y AY, AX. In other words, L is a spacing pattern.
- the simplified general formulas of the corresponding hybrid compounds may be, inter alia, those belonging to the group comprising: Po - Li - Ro - L 2 - Po; Po - Li - Ro - L 4 - Po; Po - L 2 - Ro - L 3 - A; A - L 3 - Ro - L 4 - A; L 1 , L 2 , L 3 , L 4 are spacing patterns and are the same or different from each other, whether taken singly or together.
- A is an inorganic or organic entity, optionally a polymer; and in case of presence of a plurality of A-entities per molecule of hybrid compound; said A-entities are identical to or different from one another, the organic entity A being chosen from a compound selected from the group consisting of: synthetic polymers, their copolymers or monomeric units making it possible to obtain them
- alkyls alkenyls, alkynyls, aryls and combinations thereof
- the synthetic polymers of the entity A can be synthetic polymers of average molar mass greater than 1000 g / mol, preferably greater than 10000 g / mol.
- A is chosen from a compound chosen from the group comprising: "synthetic polymeric non-saccharidic polyols, their copolymers or the monomer units making it possible to obtain them (some of them are detailed below for the Po entity) ;
- Polyorganosiloxanes their copolymers or monomeric units making it possible to obtain them;
- Polyalkylene glycols (or alternatively alkylene polyoxides), preferably polyethylene glycols (or ethylene polyoxides) and / or polypropylenes glycols (or propylene polyoxides), and / or polytetraethylene glycols, and / or their copolymers or co-oligomers, especially statisic or block copolymers or co-oligomers or polypropylene glycols and polypropylene glycols (or alternatively random or block ethylene and propylene polyoxides), these polyalkylene glycols being optionally functionalized with or on other groups, for example by or on amino groups (Jeffamines), and / or being optionally terminated on at least one end by a hydroxyl group or by an alkyl group, for example a C1-C30 alkyl;
- polyesters their copolymers or the monomeric units making it possible to obtain them
- Polybutadienes their copolymers or monomeric units making it possible to obtain them
- alkyls alkenyls, alkynyls, aryls and combinations thereof;
- this entity A may comprise polymers or copolymers chosen from the group as mentioned above, or even linear or branched, optionally crosslinked chains.
- the molar mass of this entity A is greater than or equal to 100, preferably greater than or equal to 100, and even more preferably between 100 and 50,000.
- the entity A comprises at least one POS carrying siloxy units M, D, T and / or Q, preferably at least one POS carrying siloxy units M and D, optionally T and / or or Q, and even more preferably at least one POS of type M (D) dM, M (D) d (T) t M, MQ, with d, t rational numbers greater than or equal to 0.
- d is for example understood between 1 and 1,000,000, preferably from 1 to 10,000, and t is for example between 0 and 50, preferably between 0 and 20.
- these POS are, for example linear ⁇ -functional polysiloxanes functional or functionalized in the chain. These POS can also be more or less branched structures. In practice, these POS are, for example, carriers of glycidyl ether function (s) and / or hydrogen.
- the hybrid compound Po-Ro-POS corresponds to at least one of the following formulas:
- R 2 which is identical or different, is a hydrogenocarbon group, preferably a methyl group,
- R 3 is a group of formula -Ro-Po in which Ro and Po are as defined above, - R 1 , identical or different, is a group R 2 or R 3 ,
- R is a divalent group comprising an oxygen atom, preferably a group -O-,
- n 1
- - n is an average number greater than or equal to 0
- - k and 1 are average numbers greater than or equal to 0
- o and p are average numbers greater than or equal to 0.
- m + n is between 0 and 1000000, preferably between 0 and 10000, the ratio between m and n being between 1/1 and 1/100, preferably between 1/20 and 1/50, or
- - m + n + o + p is between 0 and 1000, preferably between 0 and 300, the ratio between n + o and m + p being between 1/1 and 1/100, preferably between 1/20 and 1/50.
- the entity A can also include polyalkylene glycol type residues optionally having at least one alkyl ether terminator, for example methyl ether.
- polyalkylene glycols examples include polyoxyethylene glycols, polyoxyethylene glycols monoalkyl (e.g., methyl) ether, polyoxypropylene glycols, polyoxypropylene glycols monoalkyl (e.g., methyl) ether, polyoxytetraethylene glycols ...
- the polyamides may be constituent elements of the entity A.
- Examples of polyamides that may be mentioned include polyamides 6-6, polyamides 6, polyamides 6 monoamine, polyamines 6-10, polyamides 12-12.
- the polyesters may be constituent elements of the entity A.
- polyesters that may be mentioned include poly ⁇ -caprolactone, polylactic acid, polyadipate of ethylene glycol, polyhydroxyalkanoate, etc.
- Polystyrenes may be constituent elements of entity A.
- Examples of polystyrenes include hydroxytelechelic or mono-functional polystyrene ...
- Polybutadienes may be constituent elements of entity A.
- Examples of polybutadienes include hydroxytelechelic polybutadiene ...
- the amino acids and peptides may be constituent elements of the entity A.
- the term "peptides” designates, inter alia, oligopeptides and polypeptides, or even proteins.
- the derivatives (or analogs) of amino acids (natural or synthetic) and peptides are also covered by the invention as entity A.
- All (co) polymers capable of forming part of the entity A of the hybrid compound Po-Ro-A may be homopolymers, linear or branched or crosslinked, or else linear or branched, optionally crosslinked, block or random block copolymers. .
- the AX or AY synthon used to prepare the hybrid compound comprises a finished (co) polymer or an unfinished monomeric, oligomeric or polymer unit, intended to grow to form a polymer. finished after reaction with Po-Y or Po-X.
- alkyl, alkenyl or alkynyl chains that may be included in the A-entity comprise, for example, from 2 to 50 carbon atoms, preferably from 4 to 40, and more preferably from 4 to 30 carbon atoms.
- Silica is an example of a mineral that could enter into the constitution of entity A.
- polyol entity Po it is selected from polymeric synthetic nonsaccharide polyols, and / or from saccharides (hydrogenated or not) comprising at least two, preferably at least three monosaccharide units.
- the synthetic polymeric non-saccharide polyols may in particular have an average molecular weight of greater than 1000 g / mol, preferably greater than 10000 g / mol.
- the latter are, for example polyvinyl alcohols (partially hydrolysed or otherwise), polyhydroxyaldehydes H- [CHOH] n -CHO and / or polyhydroxyketones H- [CHOH] n -CO- [CHOH] m -H preferably comprising minus 3, more preferably at least 4 carbon atoms.
- the polymeric synthetic nonsaccharide polyols preferably have at least 3 hydroxyl units, more preferably at least 4, and even more preferably at least 10. They preferably have at least 3 repeating units, more preferably at least 4, and more preferably still at least minus 10. Note that they can be entities A.
- saccharides also known as “carbohydrates”
- saccharides include, it will be understood, monosaccharides, disaccharides, oligosaccharides and polysaccharides as well as all saccharide derivatives Saccharides, their structures and formulas, are known to those skilled in the art. It is known in particular that the saccharides have a non-reducing end and a reducing end. The latter implies the presence of an "anomeric hydroxyl” and is on the right according to the writing convention. It is also known that saccharides have OH groups.
- the carbon of the saccharide more preferably contained in the (the) bond (s) with the (the) ball (s) Ro is the "anomeric” carbon. This does not exclude that all or part of the other saccharide carbons can be connected to a Ro ball. This is all the more possible as the groups carried by the "non-anomeric" carbons do not require protection during the synthesis of the hybrid compound.
- Monosaccharides are molecules comprising a single saccharide unit (for example C5: pentose or C6: hexose), without glycosidic connection between several units of this type.
- Monosaccharides include, among others, aldoses, dialdoses, aldoketoses, ketoses, dicetoses, as well as deoxysaccharides, amino saccharides and their derivatives resulting from precursors comprising at least one carbonyl group.
- saccharides D-glucose, fructose, sorbose, mannose, galactose, talose, allose, gulose, idose, glucosamine, mannosamine, galactosamine, glucuronic acid, rhamnose, arabinose, galacturonic acid, fucose, xylose, lyxose, ribose.
- di-saccharides maltose, gentiobiose, lactose, cellobiose, isomaltose, melibiose, laminaribiose, chitobiose, xylobiose, mannobiose, sophorose, palatinose oligo-saccharides : maltotriose, isomaltotriose, maltotetraose, maltopentaose, xyloglucan, maltoheptaose, mannotriose, manninotriose, chitotriose, generally di- or oligosaccharides having, for example, ⁇ -1-4, ⁇ -1-4 or ⁇ - l-6 ....
- the polysaccharides according to the invention may be linear or branched and may comprise, for example, more than 20 monosaccharide residues or preferably more than 30 monosaccharide residues or even more particularly between 25 and 100 monosaccharide residues. These may be the same or different from each other.
- the polysaccharides according to the invention may contain linear units mono-, di-, tri-, tetra-, penta-, hexa-, hepta-, octa-, nona- or decasaccharides, preferably mono-, di-, tri- or tetrasaccharides.
- the polysaccharides may comprise at least two, at at least three, at least four, at least ten, or significantly more in the case of polysaccharide polymers, of these linear units.
- the polysaccharides according to the invention may comprise recurring saccharide units of the N-acetyl-lactosamine type or acetylated saccharide units.
- polysaccharides are: starch (preferably having at least 5 DE equivalent) and derivatives thereof such as maltodextrins, cyclodextrins and glucose syrups. pectin; - cellulose and its derivatives; galactomannans, for example guar or carob polymers and their derivatives,
- the guar or carob macro-molecule is constituted by a linear main chain constructed from monomeric ⁇ -D-mannose sugars linked together by (1-4) bonds, and ⁇ -D-galactose side units linked to ⁇ -D-mannoses by bonds (1-6).
- Natural guar is extracted from the albumen of certain plant seeds, eg Cyamopsis Tetragonalobus.]; chitin and chitosan bacterial polysaccharides hyaluronic acid
- the entity Po is different from a maltodextrin.
- the entity Po is different from a cyclodextrin. According to another particular embodiment, the entity Po is different from a glucose syrup.
- the Po entity is different from a maltodextrin and a cyclodextrin and / or a glucose syrup.
- the starch or cellulosic polysaccharides likely to form part of the polyol entity Po are preferably of natural origin, but could also be obtained synthetically.
- saccharide derivatives mention may be made in particular of: • those obtained by reduction of the carbonyl group (alditol), Those obtained by oxidation of one or more terminal groups or not so as to transform them for example into carboxylic acid groups or into carboxyalkyl groups (eg carboxymethyl),
- Those obtained by grafting one or more groups for example carboxylic acid groups, carboxyalkyl (e.g., carboxymethyl) groups, hydroxyalkyl (e.g., hydroxyethyl) groups or else alkyl (e.g., methyl) groups;
- carboxylic acid groups for example carboxylic acid groups, carboxyalkyl (e.g., carboxymethyl) groups, hydroxyalkyl (e.g., hydroxyethyl) groups or else alkyl (e.g., methyl) groups;
- Glycosides namely compounds comprising at least one saccharide and at least one aglycone (non-saccharide compound), the saccharide (s), on the one hand, and the non-saccharide component (s); saccharide (s), on the other hand, being connected to each other (or to each other) by hydrolyzable bonds
- Galactomannan derivatives in particular derivatives of guar polymers or of carob polymers, obtained by hydrolysis of guar or carob, and possibly by chemical modification (derivatization).
- Derivatisation can be used to chemically modify saccharide derivatives other than those mentioned above.
- One of the major advantages of the invention is to propose hybrid compounds whose synthesis does not require protection of sensitive groups, in particular those carried by the saccharides of the Po or A entity.
- the invention relates to a process for obtaining hybrid compounds and especially those according to the invention, as described above.
- This method of obtaining is that defined above. It comprises the four steps (i), (ii), (iii) and optionally (iv), which are detailed below by way of nonlimiting illustration. Steps (i) and (ii): The synthons implemented
- Po comprises at least one saccharide with: ⁇ Li comprising at least one amino group (e.g., terminal) having reacted with the anomeric carbon of Po,
- halogeno group for example bromo
- Po contains at least one residue (e.g. saccharide) functionalized with at least one functionalising group belonging to the group comprising the carboxylic, carboxylate, anhydride, thiol, isocyanate and epoxide with:
- ⁇ Li comprising at least one amino group (for example terminal) having reacted with the group (s) of functionalization of Po, ⁇ and / or Li from a precursor comprising at least one halo group (for example bromo) having reacted with the functionalization group (s) of the Po;
- this Po-X synthon can be characterized in that Po is a polymer comprising, for example, at least two, preferably at least 3, and more preferably still at least 10 monomer units.
- the preparation of the synthon Po-X can advantageously comprise the following essential sub-steps: a-reaction of the hydroxyl carried by the anomeric carbon of Po, since this is saccharide and / or of the group (s) functionalizing Po with an excess of at least one precursor of the Li link carrying a reactive end (preferably at least one amine function - possibly terminal - b - elimination of the precursor;
- Li corresponds to -NH- (CH 2) q> 1, with a precursor corresponding to:
- A comprises at least one saccharide with: ⁇ L 3 comprising at least one amino group (for example terminal) having reacted with the OH borne by the anomeric carbon of A,
- ⁇ and / or L 3 from a precursor comprising at least one halogeno group (for example bromo) reacted with the OHs of the Po;
- halogeno group for example bromo
- A comprises at least one residue (for example saccharide) functionalized by at least one functionalization group belonging to the group comprising carboxylic, carboxylate, anhydride, thiol, isocyanate and epoxide functionalization groups, with:
- ⁇ L 3 comprising at least one amino group (for example terminal) having reacted with the group (s) of functionalization of A, ⁇ and / or L 3 from a precursor comprising at least one halogeno group (for example bromo ) reacted with the functionalization group (s) of A;
- A comprises at least one residue (for example POS) functionalized by at least one functionalization group belonging to the group comprising hydrogen and the units bearing at least one ethylenic unsaturation, with L 3 comprising at least one at least one group (for example terminal) bearing at least one ethylenic unsaturation having reacted with the functionalization group (s) of A;
- this A-X synthon can be characterized in that this polyol is a polymer comprising, for example, at least two, preferably at least 3, and more preferably still at least 10 monomer units.
- the preparation of the synthon AX may advantageously comprise the following essential substeps: a-reaction of the hydroxyl borne by the anomeric carbon and / or of the functionalization group (s) of A with an excess of at least a precursor of the link L 3 carrying a reactive end (preferably at least one function amine-optionally terminal-and / or at least one halo group) capable of reacting with A; b- elimination of the precursor.
- L 3 corresponds to -NH- (CH 2) q> 1, with a precursor corresponding to:
- the precursor of the link L 3 could be in particular: acrylonitrile, propargyl alcohol or triethylene glycol monopropargyl.
- A comprises a POS
- the preparation of A-X can be carried out as described in Polymer 44 (2003) 6449-6455 Telechelic polydimethylsiloxane with terminal acetylenic groups prepared by phase transfer catalysis.
- Po comprises at least one saccharide with: -> L 2 comprising at least one amino group (e.g., terminal) having reacted with the anomeric carbon of Po -> and / or L 2 derived from a precursor comprising at least one halogeno group (for example bromo) having reacted with the anomeric OH or OH of the Po;
- -> L 2 comprising at least one amino group (e.g., terminal) having reacted with the anomeric carbon of Po -> and / or L 2 derived from a precursor comprising at least one halogeno group (for example bromo) having reacted with the anomeric OH or OH of the Po;
- Po contains at least one residue (e.g. saccharide) functionalized with at least one functionalising group belonging to the group comprising the carboxylic, carboxylate, anhydride, thiol, isocyanate and epoxide with:
- ⁇ and / or L 2 from a precursor comprising at least one halogeno group (for example bromo) having reacted with the group (s) functionalization of Po; 3. according to a 3rd possibility, the first two possibilities are combined.
- halogeno group for example bromo
- this Po-Y synthon can be characterized in that Po is a polymer comprising, for example, at least two, preferably at least 3, and more preferably still at least 10 monomer units.
- the preparation of the Po-Y synthon may advantageously comprise the following essential substeps: a-reaction of the hydroxyl borne by the anomeric carbon and / or the functionalization group (s) of Po with an excess of at least one precursor of the link
- L 2 carrying a reactive end (preferably at least one amine function - optionally terminal and / or at least one hydroxyl function and / or at least one halo group) capable of reacting with Po; b- elimination of the precursor;
- the precursor of the L 2 link could be:
- A comprises at least one saccharide with:
- -> L 4 comprising at least one amino group (for example terminal) having reacted with the OH borne by the anomeric carbon of A, -> and / or L 4 from a precursor comprising at least one halogeno group (for example bromo ) reacted with the OH of A;
- A comprises at least one residue (for example POS) functionalized by at least one functionalization group belonging to the group comprising carboxylic, carboxylate, anhydride, thiol, isocyanate and epoxide functionalization groups, with:
- -> and / or L 4 is derived from the NaN 3 precursor reacted with the functionalization group (s) of A epoxide type; And / or L4 comprising at least one halogeno group (for example bromo) having reacted with the functionalization group (s) of A;
- halogeno group for example bromo
- A comprises at least one residue (for example POS) functionalized with at least one functionalization group belonging to the group comprising hydrogen and the units carrying at least one ethylenic unsaturation, with L4 comprising at least one group (for example terminal) bearing at least one ethylenic unsaturation having reacted with the functionalization group (s) of A; 4.
- the first three possibilities are combined.
- this A-Y synthon may be characterized in that A is a polymer comprising, for example, at least two, preferably at least 3, and more preferably still at least 10 monomer units.
- the preparation of the AY synthon may advantageously comprise the following essential substeps: a- reaction of anomeric hydroxyl (s) and / or of the functionalization group (s) of A with an excess at least one precursor of the link L 4, which may or may not carry a reactive end (preferably at least one amine functional group - possibly terminal - and / or at least one halo group) and capable of reacting with A; b- elimination of the precursor.
- A-Y is obtained from an entity A carrying epoxide functionalization groups which is reacted with the precursor
- the precursor of the link L4 could for example be in particular: acrylonitrile, propargyl alcohol or triethylene glycol monopropargyl.
- A comprises a POS
- the preparation of A-X can be carried out as described in Polymer 44 (2003) 6449-6455 Telechelic polydimethylsiloxane with terminal acetylenic groups prepared by phase transfer catalysis.
- the mechanism of cycloaddition [step (Ui)] at the heart of the process according to the invention is a 1,3-dipolar cycloaddition mechanism of a Po-X or AY synthon with reactive units VII.2 azido and an AY synthon or Po-X reactive units VIL1 acetylenic or nitrile ("chemistry") catalyzed copper I, preferably in aqueous medium, hydroorganic or organic.
- This mechanism is particularly attractive because of its simplicity, its non-dangerous nature for operators and the environment, its low cost, among others.
- Po-X synthons and AY synthons it is possible to implement, in place of or in addition to the Po-X synthons and AY synthons, mixed Po-XY synthons each comprising at least one reactive unit X and at least one minus one reactive unit Y and mixed synthons A-XY each comprising at least one reactive unit X and at least one unit a reagent Y, so that these synthons Po-XY and A-XY are able to react together.
- the expression "of the order” means that the values concerned are given with an uncertainty, for example of plus or minus 10%.
- the cycloaddition step (iii) to be carried out in an aqueous, hydroalcoholic or organic medium capable of solubilizing and / or swelling the Po-X synthon and / or the AY synthon, with the aid of at least one metal catalyst in the ionized form, preferably Cu ++ in the presence of at least one reducing agent of Cu ++ + Cu, in situ, said reducing agent being preferably selected from the group consisting of: ascorbate, quinone , hydroquinone, vitamin K1, glutathione, cysteine, Fe 2+ , Co 2+ , applied electrical potential, metal of the group comprising Cu, Al, Be, Co, Cr, Fe, Mg, Mn, Ni, and Zn, and mixtures thereof .
- the metal catalyst in ionized form preferably Cu ++
- Cu is advantageously in the form of salt (s) (ideally sulphate) more preferably still including at least one activator comprising for example at least one acid salt (s) organic (ideally ascorbic acid) and at least one alkali metal (ideally Na).
- the CuSO 4 / sodium ascorbate system is for example quite suitable.
- the cycloaddition step (iii) is preferably carried out in a reaction medium whose temperature is between 20 and 100 ° C., preferably between 50 and 100 ° C. 80 0 C, for 0.1 to 20 hours, preferably for 0.5 to 15 hours, and more preferably for 1 to 8 hours.
- the heating of the reaction medium is carried out by any appropriate means. Microwave irradiation may constitute, e.g., an interesting heating modality.
- the reaction medium of the cycloaddition step (iii) is an aqueous, hydroorganic or organic medium preferably comprising at least one solvent chosen from:
- aprotic polar solvents preferably DiMethylFormamide (DMF), DiMethylAcetamide (DMAc), tetrahydrofuran (THF), acetone, methyl ethyl ketone, butanone;
- protic polar solvents preferably methanol, isopropyl alcohol (IPA), t-butanol (t-BuOH),
- apolar solvents preferably toluene, hexane, xylene,
- At least one chromatography preferably at least one chromatography on silica gel, using an eluent containing a mixture of a first polar solvent and at least one second less polar solvent, for example the mixture acetonitrile and water. ⁇ and / or at least one evaporation to dry the product.
- the present invention relates to the Po-X, Po-Y, A-X, AY, Po-XY and A-XY synthons according to the invention, taken as such and defined above in the scope of the description of the process according to the invention.
- the present invention also relates to the use of a hybrid compound as described above as such or as a product obtained by the process also defined above, as an ingredient in compositions chosen from the group comprising: -> detergent / surfactant compositions
- compositions also constitute another subject of the invention.
- these compositions may be an emulsion, preferably an oil-in-water emulsion comprising a hybrid compound according to the invention.
- the hybrid compounds according to the invention can in particular be presented in the form of oils. They can also be presented in dispersed or solubilized form in a vector, for example at a concentration of 10 to 90% by weight.
- the vector may advantageously be a solvent for the polymer, for example an optionally volatile silicone compound, for example a linear or cyclic polydimethylorganosiloxane such as cyclopentasiloxane, disiloxane, linear dimethicones, or a trimethylsiloxyphenyl dimeticone, or a mixture.
- the hybrid compounds according to the invention may in particular be used as an emulsifier or co-emulsifier for preparing or stabilizing emulsions. They may for example be used in emulsions of which one phase is a silicone oil. Presented as solutions in a polyorganosiloxane, for example in cyclopentasiloxane, they can be used as an emulsifier for water-in-oil or oil-in-silicone emulsions. They can also be used to compatibilize several compounds within a formulation. They can also be used as an agent for assisting the deposit of another compound, or as triggering the deposit of another compound. They can also be used as dispersing or co-dispersing agents to prepare or stabilize dispersions of particles, for example pigments.
- the hybrid compounds according to the invention have the advantages in these applications of being slightly irritating, partially biodegradable or bioabsorbable, of providing a pleasant touch, and / or of providing an advantageous spreading.
- the hybrid compounds exemplified hereinafter are oligoorganosiloxanes or polyorganosiloxanes, more specifically polyimethylsiloxanes (PDMS) with trimethylsilyl ends (MD 1 OM) modified with oligosaccharide groups (see structures A, B, C) as well as modified oligosaccharides by an alkyl chain (see structure D) according to a "click chemistry" mechanism.
- PDMS polyimethylsiloxanes
- MD 1 OM trimethylsilyl ends
- the solid is N-acetylated selectively by adding 30OmL of a solution of MeOH and Ac 2 O (5: 1 v / v). The solution is kept under magnetic stirring overnight at room temperature. The solution became completely homogeneous. After evaporation to dryness and co-evaporation with MeOH / toluene (1: 1 v / v), then lyophilization, compound 2 is obtained as a white solid (15.2 g, 36 mmol, 83%).
- Trisiloxane 9 (12 g, 35.7 mmol) is diluted in 60 ml of isopropyl alcohol (IPA) and is then added equiv. of sodium azide (11.5 g, 178.5 mmol), 40 ml of distilled water and 20 ml of glacial acetic acid to reach a pH of about 6.
- the reaction medium is stirred at 50 ° C. for 4 h.
- the reaction is monitored by TLC (9: 1 v / v Toluene / EtOAc).
- the average DP polyorganosiloxane equal to 10 11 (2 g, ⁇ 1.81 mmol) is diluted in 13 ml of isopropyl alcohol (IPA) and is then added equiv. of sodium azide (1.93 g, 9.07 mmol), 3.9 ml of distilled water and 3.3 ml of glacial acetic acid to reach a pH of about 6.
- the reaction medium is stirred at 50 ° C. for 7 hrs. .
- the reaction is monitored by 1 H NMR and stopped when the starting material is almost completely consumed.
- reaction medium is diluted with diethyl ether (30 mL) and extracted with water (10 mL). The organic phase is recovered, dried over Na 2 SO 4 , filtered and then evaporated to dryness to give compound 12 (1.95g, 89%) as a colorless oil and sufficiently pure to be used for the next reaction.
- the solution is brought to 50 ° C. in a sealed tube and stirred for 1 hour.
- the reaction is monitored by TLC (CH 3 CN / H 2 O - 7: 3 v / v).
- the medium is then diluted in MeOH (5 mL) and then evaporated to dryness in the presence of silica. The residue is deposited on a column of silica gel. After purification by rapid chromatography on silica gel (acetonitrile / water: 9-1 v / v), the compound is obtained in a yield of 89% (168 mg, 210 ⁇ mol) and in the form of a white powder after lyophilization.
- the solution is brought to 50 ° C. in an IL flask and stirred for 1 hr.
- the reaction is monitored by TLC (CH 3 CN / H 2 O - 7: 3 v / v).
- the medium is then diluted in MeOH (25 mL) and then evaporated to dryness in the presence of silica.
- the residue is deposited on a column of silica gel. After purification by rapid chromatography on silica gel (acetonitrile / water: 8-2 v / v), we find a contamination by copper (II) fractions presenting our compounds 16, 17 and 18, visualized by a bluish color.
- the solution is brought to 50 ° C. in a sealed tube and stirred for 1 hour.
- the reaction is monitored by TLC (CH 3 CN / H 2 O - 7: 3 v / v).
- the medium is then diluted in MeOH (25 mL) and then evaporated to dryness in the presence of silica. The residue is deposited on a column of silica gel. After purification by rapid chromatography on silica gel (acetonitrile / water: 8-2 v / v), the compounds 19, consisting of a multitude of combinations of condensation products and impossible to determine, are obtained with a mass yield of 81%. % (583mg) and in the form of a white powder after lyophilization.
- the solution is brought to 50 ° C. in a sealed tube and stirred for 1 hour.
- the reaction is monitored by TLC (CH 3 CN / H 2 O - 7: 3 v / v).
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Silicon Polymers (AREA)
- Saccharide Compounds (AREA)
- Polyethers (AREA)
- Cosmetics (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009510443A JP2009537484A (ja) | 2006-05-15 | 2007-05-15 | ポリオールと、少なくとも1種のポリマー性または非ポリマー性の他の分子部分、特にポリオルガノシロキサン型の分子部分をベースとするハイブリッド化合物、その製造方法、およびその用途 |
EP07729152A EP2024382A2 (fr) | 2006-05-15 | 2007-05-15 | Composés hybrides à base de polyol(s) et à base d'au moins une autre entité moléculaire, polymères ou non, notamment de type polyorganosiloxane, son procédé de préparation et ses applications |
US12/300,470 US20100048738A1 (en) | 2006-05-15 | 2007-05-15 | Hybrid compounds based on polyol(s) and at least one other molecular entity, polymeric or non-polymeric, in particular of the polyorganosiloxane type, process for the preparation thereof, and applications thereof |
BRPI0711835-0A BRPI0711835A2 (pt) | 2006-05-15 | 2007-05-15 | compostos hìbridos à base de poliol(is) e à base de pelo menos uma outra entidade molecular, poliméricos ou não, notadamente do tipo poliorganosiloxana, processo de preparação dos mesmos e suas aplicações |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0651744A FR2900929B1 (fr) | 2006-05-15 | 2006-05-15 | Composes hybrides a base de polyol(s) et a base d'au moins une autre entite moleculaire, polymeres ou non, notamment de type polyorganosiloxane, son procede de preparation et ses apllications |
FR0651745A FR2900931A1 (fr) | 2006-05-15 | 2006-05-15 | Composes hybrides a base de silicones et a base d'au moins une autre entite moleculaire, polymere ou non, notamment de type polyol(s), leur procede de preparation et leurs applications |
FR0651745 | 2006-05-15 | ||
FR0651744 | 2006-05-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007132005A2 true WO2007132005A2 (fr) | 2007-11-22 |
WO2007132005A3 WO2007132005A3 (fr) | 2008-04-24 |
Family
ID=38324142
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2007/054691 WO2007132000A1 (fr) | 2006-05-15 | 2007-05-15 | Composes hybrides a base de silicones et a base d'au moins une autre entite moleculaire, polymere ou non, notamment de type polyol(s), leur procede de preparation et leurs applications |
PCT/EP2007/054702 WO2007132005A2 (fr) | 2006-05-15 | 2007-05-15 | Composés hybrides à base de polyol(s) et à base d'au moins une autre entité moléculaire, polymères ou non, notamment de type polyorganosiloxane, son procédé de préparation et ses applications |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2007/054691 WO2007132000A1 (fr) | 2006-05-15 | 2007-05-15 | Composes hybrides a base de silicones et a base d'au moins une autre entite moleculaire, polymere ou non, notamment de type polyol(s), leur procede de preparation et leurs applications |
Country Status (4)
Country | Link |
---|---|
EP (2) | EP2024422A1 (fr) |
JP (1) | JP2009537484A (fr) |
BR (1) | BRPI0711835A2 (fr) |
WO (2) | WO2007132000A1 (fr) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102008040886A1 (de) | 2008-07-31 | 2010-02-04 | Wacker Chemie Ag | Durch Click-Reaktion vernetzbare mehrkomponentige Siliconzusammensetzungen |
US8865857B2 (en) | 2010-07-01 | 2014-10-21 | Sofradim Production | Medical device with predefined activated cellular integration |
CN104403129A (zh) * | 2014-11-07 | 2015-03-11 | 上海交通大学 | 双组份交联剂及其制备方法、用途 |
US9247931B2 (en) | 2010-06-29 | 2016-02-02 | Covidien Lp | Microwave-powered reactor and method for in situ forming implants |
US9510810B2 (en) | 2009-02-21 | 2016-12-06 | Sofradim Production | Medical devices incorporating functional adhesives |
US9775928B2 (en) | 2013-06-18 | 2017-10-03 | Covidien Lp | Adhesive barbed filament |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20061726A1 (it) * | 2006-09-11 | 2008-03-12 | Fidia Farmaceutici | Derivati crosslinkati a base di acido ialuronico reticolato via click chemistry |
FR2923828B1 (fr) * | 2007-11-16 | 2010-02-19 | Rhodia Operations | Composes hybrides a base de polyasaccharides(s) et d'au moins un polyoxyalkylene, leur procede de preparation et leurs applications |
US20110077365A1 (en) * | 2008-12-29 | 2011-03-31 | Gilbert Yu | Preparation of organosilicon-containing triazoles |
US8247614B2 (en) * | 2009-06-17 | 2012-08-21 | E I Du Pont De Nemours And Company | Copolycondensation polymerization of fluoropolymers |
CN104226283B (zh) * | 2014-08-28 | 2017-03-29 | 华东理工大学 | 聚乙烯醇涂覆型色谱固定相及其制备方法与应用 |
JP2016079242A (ja) * | 2014-10-14 | 2016-05-16 | ナガセケムテックス株式会社 | 自己組織化能を有する化合物、自己組織化パターン形成用材料、及び、自己組織化した薄膜の製造方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3168544A (en) * | 1961-08-23 | 1965-02-02 | Union Carbide Corp | Preparation of cyanoalkylsilanes |
US6340670B1 (en) * | 1998-11-24 | 2002-01-22 | American Home Products Corporation | Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation |
DE10132942A1 (de) * | 2001-07-06 | 2003-01-23 | Degussa | Siloxan-Oligomere, Verfahren zu deren Herstellung und deren Verwendung |
CN1394867A (zh) * | 2001-07-06 | 2003-02-05 | 中国科学院生态环境研究中心 | 可作药物的寡糖和其制备方法及含该寡糖的药物组合物 |
EP2226316B1 (fr) * | 2002-05-30 | 2016-01-13 | The Scripps Research Institute | Ligation d'azides et d'acetylénes catalysée par le cuivre |
FR2867480B1 (fr) * | 2004-03-10 | 2008-08-08 | Rhodia Chimie Sa | Polymere greffe comprenant un squelette polyorganosiloxane et des motifs glycoside |
EP1602663A1 (fr) * | 2004-06-04 | 2005-12-07 | Chiralix B.V. | Glycopeptides et/ou glycoaminoacides liés par une liaison triazole |
-
2007
- 2007-05-15 EP EP07729143A patent/EP2024422A1/fr not_active Withdrawn
- 2007-05-15 JP JP2009510443A patent/JP2009537484A/ja active Pending
- 2007-05-15 EP EP07729152A patent/EP2024382A2/fr not_active Withdrawn
- 2007-05-15 BR BRPI0711835-0A patent/BRPI0711835A2/pt not_active Application Discontinuation
- 2007-05-15 WO PCT/EP2007/054691 patent/WO2007132000A1/fr active Application Filing
- 2007-05-15 WO PCT/EP2007/054702 patent/WO2007132005A2/fr active Application Filing
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102008040886A1 (de) | 2008-07-31 | 2010-02-04 | Wacker Chemie Ag | Durch Click-Reaktion vernetzbare mehrkomponentige Siliconzusammensetzungen |
EP2151467A1 (fr) | 2008-07-31 | 2010-02-10 | Wacker Chemie AG | Composition silicone comprenant plusieurs composants et réticulable par "Click-Réaction" |
JP2010037561A (ja) * | 2008-07-31 | 2010-02-18 | Wacker Chemie Ag | クリック反応によって架橋可能な多成分系シリコーン組成物 |
US8071708B2 (en) | 2008-07-31 | 2011-12-06 | Wacker Chemie Ag | Click-reaction crosslinkable multicomponent silicone compositions |
US9510810B2 (en) | 2009-02-21 | 2016-12-06 | Sofradim Production | Medical devices incorporating functional adhesives |
US9247931B2 (en) | 2010-06-29 | 2016-02-02 | Covidien Lp | Microwave-powered reactor and method for in situ forming implants |
US8865857B2 (en) | 2010-07-01 | 2014-10-21 | Sofradim Production | Medical device with predefined activated cellular integration |
US9775928B2 (en) | 2013-06-18 | 2017-10-03 | Covidien Lp | Adhesive barbed filament |
CN104403129A (zh) * | 2014-11-07 | 2015-03-11 | 上海交通大学 | 双组份交联剂及其制备方法、用途 |
Also Published As
Publication number | Publication date |
---|---|
EP2024382A2 (fr) | 2009-02-18 |
EP2024422A1 (fr) | 2009-02-18 |
BRPI0711835A2 (pt) | 2011-12-13 |
WO2007132005A3 (fr) | 2008-04-24 |
WO2007132000A1 (fr) | 2007-11-22 |
JP2009537484A (ja) | 2009-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007132005A2 (fr) | Composés hybrides à base de polyol(s) et à base d'au moins une autre entité moléculaire, polymères ou non, notamment de type polyorganosiloxane, son procédé de préparation et ses applications | |
US20100048738A1 (en) | Hybrid compounds based on polyol(s) and at least one other molecular entity, polymeric or non-polymeric, in particular of the polyorganosiloxane type, process for the preparation thereof, and applications thereof | |
EP1322673B1 (fr) | Polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine | |
WO2009063082A1 (fr) | Composés hybrides à base de polysaccharide(s) et d'au moins un polyoxyalkylène, leur procédé de préparation et leurs applications. | |
EP2313075A2 (fr) | Compositions domestiques et de soins personnels | |
DE60218891T2 (de) | Saccharide-enthaltende funktionelle organopolycarbosiloxane und verfahren zu deren herstellung | |
Racles et al. | Synthesis and characterization of water soluble saccharide functionalized polysiloxanes and their use as polymer surfactants for the stabilization of polycaprolactone nanoparticles | |
EP4061854B1 (fr) | Silicium glycan et procédé de préparation | |
EP1446440B1 (fr) | Organopolysiloxanes fonctionnels a residus saccharidiques et leur procede de preparation | |
CA2719279A1 (fr) | Polysiloxanes fonctionnalises, leur procede de preparation et leurs utilisations | |
EP1742988B1 (fr) | Polymere greffe comprenant un squelette polyorganosiloxane et des motifs glycoside | |
WO2021101679A1 (fr) | Procédé de préparation d'un glycane de silicium | |
FR2873123A1 (fr) | Nouveaux glycopolymeres, leurs utilisations, et monomeres utiles pour leur preparation | |
FR2900931A1 (fr) | Composes hybrides a base de silicones et a base d'au moins une autre entite moleculaire, polymere ou non, notamment de type polyol(s), leur procede de preparation et leurs applications | |
FR2900929A1 (fr) | Composes hybrides a base de polyol(s) et a base d'au moins une autre entite moleculaire, polymeres ou non, notamment de type polyorganosiloxane, son procede de preparation et ses apllications | |
EP2350108A2 (fr) | Composes c-glycosides et procedes de preparation de composes c-glycosides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 2007729152 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 9483/DELNP/2008 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009510443 Country of ref document: JP Ref document number: 200780017708.6 Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12300470 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: PI0711835 Country of ref document: BR Kind code of ref document: A2 Effective date: 20081114 |